AZN logo

AstraZeneca (AZN) Long term liabilities

Annual long term liabilities:

$35.30B+$3.89B(+12.37%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AZN annual total long term liabilities is $35.30 billion, with the most recent change of +$3.89 billion (+12.37%) on December 31, 2024.
  • During the last 3 years, AZN annual long term liabilities has fallen by -$8.18 billion (-18.82%).
  • AZN annual long term liabilities is now -18.82% below its all-time high of $43.48 billion, reached on December 31, 2021.

Performance

AZN Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

quarterly long term liabilities:

$35.99B(NaN%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN quarterly total long term liabilities is $35.99 billion
  • Over the past year, AZN quarterly long term liabilities has increased by +$102.00 million (+0.28%).
  • AZN quarterly long term liabilities is now -17.56% below its all-time high of $43.66 billion, reached on September 30, 2021.

Performance

AZN quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

AZN Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.4%+0.3%
3 y3 years-18.8%-12.6%
5 y5 years+23.1%+28.8%

AZN Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.8%+12.4%-12.6%+18.9%
5 y5-year-18.8%+23.1%-17.6%+28.8%
alltimeall time-18.8%+2135.9%-17.6%+2183.8%

AZN Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$35.99B(-5.8%)
Dec 2024
$35.30B(+12.4%)
-
Sep 2024
-
$38.19B(+5.6%)
Jun 2024
-
$36.18B(+0.8%)
Mar 2024
-
$35.89B(+18.5%)
Dec 2023
$31.41B(-5.2%)
-
Sep 2023
-
$30.28B(-7.6%)
Jun 2023
-
$32.75B(-9.1%)
Mar 2023
-
$36.02B(+8.7%)
Dec 2022
$33.13B(-23.8%)
$33.13B(-3.1%)
Sep 2022
-
$34.18B(-11.9%)
Jun 2022
-
$38.81B(-5.7%)
Mar 2022
-
$41.17B(-5.3%)
Dec 2021
$43.48B(+41.2%)
$43.48B(-0.4%)
Sep 2021
-
$43.66B(+22.2%)
Jun 2021
-
$35.73B(+23.3%)
Mar 2021
-
$28.97B(-5.9%)
Dec 2020
$30.78B(+7.4%)
$30.78B(-2.4%)
Sep 2020
-
$31.55B(+12.3%)
Jun 2020
-
$28.09B(+0.5%)
Mar 2020
-
$27.95B(-2.5%)
Dec 2019
$28.66B(-5.4%)
$28.66B(-5.9%)
Sep 2019
-
$30.46B(-1.0%)
Jun 2019
-
$30.78B(+0.0%)
Mar 2019
-
$30.77B(+1.5%)
Dec 2018
$30.32B(-0.0%)
$30.32B(-7.2%)
Sep 2018
-
$32.66B(+9.3%)
Jun 2018
-
$29.87B(-2.2%)
Mar 2018
-
$30.54B(+0.7%)
Dec 2017
$30.33B(-0.9%)
$30.33B(-12.5%)
Sep 2017
-
$34.68B(+1.8%)
Jun 2017
-
$34.05B(+10.7%)
Mar 2017
-
$30.75B(+0.5%)
Dec 2016
$30.60B(+14.7%)
$30.60B(-7.1%)
Sep 2016
-
$32.93B(-5.1%)
Jun 2016
-
$34.69B(+9.3%)
Mar 2016
-
$31.75B(+19.0%)
Dec 2015
$26.68B(+23.4%)
$26.68B(+28.8%)
Sep 2015
-
$20.71B(-0.0%)
Jun 2015
-
$20.72B(-1.3%)
Mar 2015
-
$20.99B(-2.9%)
Dec 2014
$21.62B(+30.3%)
$21.62B(+8.8%)
Sep 2014
-
$19.87B(-1.4%)
Jun 2014
-
$20.16B(-1.2%)
Mar 2014
-
$20.40B(+22.9%)
Dec 2013
$16.59B(+5.8%)
$16.59B(+3.7%)
Sep 2013
-
$16.00B(+4.0%)
Jun 2013
-
$15.38B(-3.8%)
Mar 2013
-
$15.98B(+1.9%)
Dec 2012
$15.69B(+15.2%)
$15.69B(-2.3%)
Sep 2012
-
$16.06B(+11.9%)
Jun 2012
-
$14.35B(+8.4%)
Mar 2012
-
$13.24B(-2.7%)
Dec 2011
$13.61B(-14.6%)
$13.61B(-1.1%)
Sep 2011
-
$13.77B(-12.6%)
Jun 2011
-
$15.75B(-1.4%)
Mar 2011
-
$15.97B(+0.3%)
DateAnnualQuarterly
Dec 2010
$15.93B(-3.2%)
$15.93B(-7.5%)
Sep 2010
-
$17.23B(+7.1%)
Jun 2010
-
$16.08B(-0.7%)
Mar 2010
-
$16.19B(-1.6%)
Dec 2009
$16.46B(-5.8%)
$16.46B(-4.5%)
Sep 2009
-
$17.23B(+0.7%)
Jun 2009
-
$17.11B(+1.1%)
Mar 2009
-
$16.94B(-3.1%)
Dec 2008
$17.48B(-2.1%)
$17.48B(-0.2%)
Sep 2008
-
$17.52B(-3.3%)
Jun 2008
-
$18.12B(+1.2%)
Mar 2008
-
$17.91B(+0.3%)
Dec 2007
$17.86B(+252.2%)
$17.86B(+13.9%)
Sep 2007
-
$15.68B(+103.6%)
Jun 2007
-
$7.70B(+48.2%)
Mar 2007
-
$5.19B(+2.5%)
Dec 2006
$5.07B(+17.6%)
$5.07B(-3.5%)
Sep 2006
-
$5.25B(+4.1%)
Jun 2006
-
$5.04B(-0.5%)
Mar 2006
-
$5.07B(+17.6%)
Dec 2005
$4.31B(-5.6%)
$4.31B(-2.4%)
Sep 2005
-
$4.42B(-2.2%)
Jun 2005
-
$4.52B(+4.8%)
Mar 2005
-
$4.31B(-5.6%)
Dec 2004
$4.57B(+74.3%)
$4.57B(+63.6%)
Sep 2004
-
$2.79B(-39.1%)
Jun 2004
-
$4.58B(+26.5%)
Mar 2004
-
$3.62B(+38.2%)
Dec 2003
$2.62B(+22.8%)
$2.62B(+9.5%)
Sep 2003
-
$2.39B(+4.4%)
Jun 2003
-
$2.29B(+4.3%)
Mar 2003
-
$2.20B(+3.0%)
Dec 2002
$2.13B(-10.6%)
$2.13B(+2.5%)
Sep 2002
-
$2.08B(+1.6%)
Jun 2002
-
$2.05B(-9.5%)
Mar 2002
-
$2.26B(-5.1%)
Dec 2001
$2.39B(+19.5%)
$2.39B(-11.9%)
Sep 2001
-
$2.71B(+4.0%)
Jun 2001
-
$2.61B(+1.3%)
Mar 2001
-
$2.57B(+28.8%)
Dec 2000
$2.00B(-18.7%)
$2.00B(-16.1%)
Sep 2000
-
$2.38B(-3.9%)
Jun 2000
-
$2.48B(+24.4%)
Mar 2000
-
$1.99B(-18.8%)
Dec 1999
$2.46B(+33.0%)
$2.46B(+3.3%)
Sep 1999
-
$2.38B(-4.3%)
Jun 1999
-
$2.48B(+34.5%)
Dec 1998
$1.85B(+16.9%)
$1.85B(+17.1%)
Jun 1998
-
$1.58B(-0.2%)
Dec 1997
$1.58B(-7.1%)
$1.58B(-7.1%)
Dec 1996
$1.70B(-0.4%)
$1.70B(-0.4%)
Dec 1995
$1.71B(+4.7%)
$1.71B(+4.4%)
Jun 1995
-
$1.63B(+0.3%)
Dec 1994
$1.63B(+1.2%)
$1.63B(+1.2%)
Dec 1993
$1.61B(-21.5%)
$1.61B
Dec 1992
$2.05B(-44.8%)
-
Dec 1991
$3.71B(-2.3%)
-
Dec 1990
$3.80B
-

FAQ

  • What is AstraZeneca annual total long term liabilities?
  • What is the all time high annual long term liabilities for AstraZeneca?
  • What is AstraZeneca annual long term liabilities year-on-year change?
  • What is AstraZeneca quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for AstraZeneca?
  • What is AstraZeneca quarterly long term liabilities year-on-year change?

What is AstraZeneca annual total long term liabilities?

The current annual long term liabilities of AZN is $35.30B

What is the all time high annual long term liabilities for AstraZeneca?

AstraZeneca all-time high annual total long term liabilities is $43.48B

What is AstraZeneca annual long term liabilities year-on-year change?

Over the past year, AZN annual total long term liabilities has changed by +$3.89B (+12.37%)

What is AstraZeneca quarterly total long term liabilities?

The current quarterly long term liabilities of AZN is $35.99B

What is the all time high quarterly long term liabilities for AstraZeneca?

AstraZeneca all-time high quarterly total long term liabilities is $43.66B

What is AstraZeneca quarterly long term liabilities year-on-year change?

Over the past year, AZN quarterly total long term liabilities has changed by +$102.00M (+0.28%)
On this page